Scrutiniseing the market access situation for people with rare bleeding disorders.
The nanomedicines market is worth billions. Tarun Pandotra reviews developments in the sector.
The steps required for successful market access.
Challenges in rare disease market research and the role of online research.
Pharma companies can differentiate themselves and win support if they take actions that patients find informative.
How many pieces are left of the puzzle?
Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?